ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2008

Sep 2, 2008

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2008-08-21

Reporting Person: H.I.G. ONCOGENEX, INC. (10% Owner)
Reporting Person: H.I.G. KEY CORP (10% Owner)
Reporting Person: H.I.G. HORIZON CORP (10% Owner)
Reporting Person: MNAYMNEH SAMI (10% Owner)
Reporting Person: TAMER ANTHONY (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	733912	Direct

Footnotes

F1: These securities include 209,688 shares that remain in escrow pending the achievement of certain milestones, as set forth in the Arrangement Agreement dated May 27, 2008 between Sonus Pharmaceuticals, Inc. and OncoGenex Technologies Inc., which is included as Exhibit 2.1 to the Issuer's Current Report on Form 8-K (File No. 0-21243) filed with the Securities and Exchange Commission on May 30, 2008, and incorporated herein by reference. If such milestones are not satisfied prior to August 21, 2014, all shares remaining in escrow will be cancelled.

F2: These shares are owned directly by H.I.G. Horizon Corporation, which is a wholly-owned subsidiary of H.I.G. Key Corporation which is a wholly-owned subsidiary of H.I.G. Oncogenex, Inc. Sami W. Mnaymneh and Anthony Tamer are the shareholders of HIG-GP II, Inc., the general partner and managing member, respectively, of the two entities which are indirectly the majority shareholders of H.I.G. Oncogenex, Inc. H.I.G. Key Corporation and H.I.G. Oncogenex, Inc. and Messrs. Mnaymneh and Tamer may be deemed to be indirect beneficial owners of the reported securities, but disclaim beneficial ownership in the securities, except to the extent of its or his pecuniary interest in the shares.